Company Filing History:
Years Active: 1989
Title: The Innovations of Nicholaos K Hrakas
Introduction
Nicholaos K Hrakas is a notable inventor based in Chesterfield, MO (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for medical research and therapeutic applications.
Latest Patents
Hrakas holds a patent for a monoclonal antibody specific for human colon fibroblast-derived tissue plasminogen activator (t-PA). This invention is crucial for immunoaffinity chromatography purification of t-PA and for determining t-PA levels in biological samples. The patent highlights his innovative approach to addressing challenges in the field of biochemistry.
Career Highlights
Hrakas is associated with Monsanto Company, where he has contributed to various research initiatives. His expertise in monoclonal antibodies has positioned him as a valuable asset in the biotechnology sector. His work continues to influence advancements in medical diagnostics and treatment.
Collaborations
Hrakas has collaborated with notable colleagues, including Jon P Schaumann and Jitka V Olander. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Nicholaos K Hrakas exemplifies the spirit of innovation in biotechnology through his patent and contributions at Monsanto Company. His work on monoclonal antibodies is paving the way for future advancements in medical science.